Device Gastroenterology

C2 Cryoballoon

Payments companies reported to CMS as associated with C2 Cryoballoon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$47Kassociated payments (2023-2025)
470clinicians with associated payments
1company reporting

By year

2023 $3,343
2024 $26K
2025 $18K

Payments reported as associated with C2 Cryoballoon, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $34K
Colon & Rectal Surgery $2,347
Otolaryngology $1,952
Internal Medicine $1,606
Surgery $789
Nephrology (Internal Medicine) $676

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with C2 Cryoballoon

These are the largest totals companies reported as associated with C2 Cryoballoon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Girish Mishra Winston Salem, NC Gastroenterology (Internal Medicine) $2,591.98
Abhinav Sankineni Philadelphia, PA Gastroenterology (Internal Medicine) $2,139.40
Jack Ramage Wilmington, NC Gastroenterology (Internal Medicine) $1,157.42
Marcia Canto Baltimore, MD Gastroenterology (Internal Medicine) $1,089.71
Toufic Kachaamy Scottsdale, AZ Gastroenterology (Internal Medicine) $1,050.29
David Forcione Boston, MA Gastroenterology (Internal Medicine) $744.44
Allison Schulman Ann Arbor, MI Gastroenterology (Internal Medicine) $736.01
Kalpesh Patel Calabasas, CA Nephrology (Internal Medicine) $675.51
Marvin Ryou Boston, MA Gastroenterology (Internal Medicine) $675.50
James Leavitt Miami, FL Gastroenterology (Internal Medicine) $581.50

Prescribed C2 Cryoballoon?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.